DD285606A5 - Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen - Google Patents

Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen Download PDF

Info

Publication number
DD285606A5
DD285606A5 DD89331045A DD33104589A DD285606A5 DD 285606 A5 DD285606 A5 DD 285606A5 DD 89331045 A DD89331045 A DD 89331045A DD 33104589 A DD33104589 A DD 33104589A DD 285606 A5 DD285606 A5 DD 285606A5
Authority
DD
German Democratic Republic
Prior art keywords
group
formula
carbon atoms
radical
heparin
Prior art date
Application number
DD89331045A
Other languages
German (de)
English (en)
Inventor
Maurice Petitou
Jean-Claude Lormeau
Jean Choay
Original Assignee
K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K filed Critical K
Publication of DD285606A5 publication Critical patent/DD285606A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
DD89331045A 1988-07-21 1989-07-21 Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen DD285606A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809885A FR2634485B1 (fr) 1988-07-21 1988-07-21 Glycosaminoglycanes selectivement o-acyles, leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DD285606A5 true DD285606A5 (de) 1990-12-19

Family

ID=9368648

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89331045A DD285606A5 (de) 1988-07-21 1989-07-21 Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen

Country Status (23)

Country Link
EP (1) EP0356275B1 (es)
JP (1) JPH0273801A (es)
KR (1) KR910002889A (es)
AT (1) ATE108804T1 (es)
AU (1) AU620632B2 (es)
DD (1) DD285606A5 (es)
DE (1) DE68916878T2 (es)
DK (1) DK362789A (es)
ES (1) ES2056239T3 (es)
FI (1) FI893518A (es)
FR (1) FR2634485B1 (es)
HU (1) HU206222B (es)
IE (1) IE892367L (es)
IL (1) IL91058A0 (es)
MA (1) MA21602A1 (es)
NO (1) NO892986L (es)
NZ (1) NZ230041A (es)
OA (1) OA09125A (es)
PT (1) PT91249B (es)
RU (1) RU1831487C (es)
TN (1) TNSN89082A1 (es)
YU (1) YU172789A (es)
ZA (1) ZA895581B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
US5834444A (en) * 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US5990095A (en) 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5498775A (en) * 1994-11-07 1996-03-12 American Home Products Corporation Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them
US5565432A (en) * 1994-11-07 1996-10-15 American Home Products Corporation Smooth muscle cell proliferation inhibitors
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
US7081448B2 (en) 1998-11-24 2006-07-25 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6664243B1 (en) 1998-11-24 2003-12-16 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) 1998-11-24 2002-03-26 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6339064B1 (en) 1998-11-24 2002-01-15 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) 1998-11-24 2001-07-10 American Home Products Corp. Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7132402B2 (en) 1998-11-24 2006-11-07 Wyeth Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6340670B1 (en) 1998-11-24 2002-01-22 American Home Products Corporation Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2317305A1 (en) 2000-08-29 2002-02-28 Tassos P. Anastassiades Method of enhancing chondrocyte cell growth and glycosaminoglycan production
KR20030057040A (ko) * 2001-12-28 2003-07-04 주식회사 효성 글루코사민 유도체 및 그의 제조 방법
KR100790007B1 (ko) * 2006-12-28 2008-01-02 경상대학교산학협력단 미색류 껍질로부터 글리코사미노글리칸의 정제방법
CN103209997B (zh) * 2010-09-14 2016-03-16 国立大学法人宫崎大学 高纯度肝素及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066M (fr) * 1963-08-07 1965-01-18 Roussel Uclaf Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
JPS469327B1 (es) * 1966-03-31 1971-03-09
JPS52111983A (en) * 1976-03-18 1977-09-20 Teijin Ltd Preparation of heparin derivatives
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
JP5410580B1 (ja) * 2012-08-09 2014-02-05 日本特殊陶業株式会社 配線基板

Also Published As

Publication number Publication date
DE68916878D1 (de) 1994-08-25
DK362789D0 (da) 1989-07-21
AU620632B2 (en) 1992-02-20
IE892367L (en) 1990-01-21
AU3885689A (en) 1990-01-25
MA21602A1 (fr) 1990-04-01
HU206222B (en) 1992-09-28
EP0356275A1 (fr) 1990-02-28
ATE108804T1 (de) 1994-08-15
RU1831487C (ru) 1993-07-30
IL91058A0 (en) 1990-02-09
FI893518A0 (fi) 1989-07-21
OA09125A (fr) 1991-10-31
FR2634485B1 (fr) 1992-02-28
YU172789A (en) 1991-08-31
DK362789A (da) 1990-01-22
NZ230041A (en) 1991-09-25
FI893518A (fi) 1990-01-22
NO892986L (no) 1990-01-22
ES2056239T3 (es) 1994-10-01
PT91249B (pt) 1995-05-04
DE68916878T2 (de) 1995-03-16
KR910002889A (ko) 1991-02-26
JPH0273801A (ja) 1990-03-13
HUT50489A (en) 1990-02-28
TNSN89082A1 (fr) 1991-02-04
ZA895581B (en) 1990-04-25
EP0356275B1 (fr) 1994-07-20
PT91249A (pt) 1990-02-08
NO892986D0 (no) 1989-07-20
FR2634485A1 (fr) 1990-01-26

Similar Documents

Publication Publication Date Title
DE68917009T2 (de) Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften.
DE3851973T2 (de) Heparine mit niedrigem Molekulargewicht und regelmässiger Struktur, ihre Herstellung und biologische Verwendungen.
DD285606A5 (de) Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen
DE69621528T2 (de) Anti-inflamatorische agenzien
DE69124590T2 (de) Glykosaminoglykan gemischt mit phospholipid oder lipid, seine herstellung und krebszellenmetastaseninhibitor
DE69023957T2 (de) Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung.
AT398976B (de) Gemische von polysacchariden mit niedrigem molekulargewicht, deren herstellungsverfahren und verwendung
EP0265865B1 (de) Blutersatzmittel
DE60125154T2 (de) Teildesulfatierte glykosaminoglykanderivate mit antiangiogenischer aktivität und ohne antikoagulierender wirkung
DE2833898C2 (es)
DE69012154T2 (de) Heparinderivate und Verfahren zu ihrer Herstellung.
DE60009574T2 (de) Chondroitinsulfat aus lachsen
DE3750036T2 (de) Verfahren zur Depolymerisierung von Heparin zum Erhalten eines Heparins mit niedrigem Molekulargewicht und einer antithrombotischen Aktivität.
DE68921633T2 (de) Oligosaccharide mit antiatherosclerotischer wirkung.
DE69228362T2 (de) Hochmolekulare, N,O-sulfatierte Heparosane; Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DD251355A5 (de) Verfahren zur herstellung von oligosacchariden
DE3422518A1 (de) Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
DE69814140T2 (de) Kohlenhydrat-derivate
DE69900718T2 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69223153T2 (de) Dermatansulfat mit trombolytischer wirkung und arzneiformen welche dieses enthalten
DE68910577T2 (de) Mittel gegen den AIDS-Virus.
DE69908298T2 (de) Pentasaccharide, verfahren zu ihrer herstellung und pharmazeutische zubereitungen die sie enthalten
DE69706418T2 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69027256T2 (de) Sulfatiertes polysaccharid, dessen pharmazeutisch verträgliche salze, dessen herstellung und medikament, das dieses als wirksstoff enthält
DE602004012314T2 (de) Niedermolekulare polysaccharide mit antithrombotischer wirkung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee